Acquired Disorders of Platelet Function

Acquired Disorders of Platelet Function (Part II)151Am J Cardiol 1994;74:720-3.188. Jimenez AH, Stubbs ME, Tofler GH, et al. Rapidityand duration of platelet suppression by enteric-coatedaspirin in healthy young men. Am J Cardiol 1992:258-62.189. Patrono C. Aspirin as an antiplatelet drug. N EnglJ Med 1994;330:1287.190. Kyrle PA, Eichler HG, Jager U, Lechner K. Inhibitionof prostacyclin and thromboxane A 2 generation bylow-dose aspirin at the site of plug formation in manin vivo. Circulation 1987;75:1025.191. ClarkeRJ,MayoG,PriceP,FitzGeraldGA. Suppression of thromboxaneA 2 but not systemic prostacyclinby controlled-release aspirin. N EnglJ Med 1991;325:1137.192. Jaffe EQ, Weksler BB. Recovery of endothelial cellprostacyclin production after inhibition by low dosesof aspirin. J Clin Invest 1979;63:532.193. Pedersen AK, FitzGerald GA. Dose-related kinetics ofaspirin: Presystemic acetylation of platelet cyclooxygenase.N Engl J Med 1984;311:1206-11.194. Mielke CH Jr. Aspirin prolongation of the templatebleeding time: Influence of venostasis and directionof incision. Blood 1982;60:1139.195. Kallmann R, Nieuwenhuis HK, de Groot PG, et al.Effects of low doses of aspirin, 10 mg and 30 mgdaily, on bleeding time, thromboxane production and6-keto-PGF1-a excretion in healthy subjects. ThrombRes 1987;45:355-61.196. Harker LA, Slichter SJ. The bleeding time as ascreening test for evaluation of platelet function. NEngl J Med 1972;287:155-9.197. O’Laughlin JC, Hoftiezer JW, Mahoney JP, Ivey KJ.Does aspirin prolong bleeding from gastric biopsiesin man? Gastrointest Endosc 1981;27:1-5.198. Eyster ME, Gordon RA, Ballard JO. The bleedingtime is longer than normal in hemophilia. Blood1981;58:719-23.199. Kaneshiro MM, Mielke CH Jr, Kasper CK, RapaportSI. Bleeding time after aspirin in disorders ofintrinsic clotting. N Engl J Med 1969;281:1039-42.200. Despotis GJ, Filos KS, Zoys TN, et al. Factorsassociated with excessive postoperative blood lossand hemostatic transfusion requirements: A multivariate analysis in cardiac surgical patients. AnesthAnalg 1996;82:13-21.201. Czapek EE, Deykin D, Salzman E, et al. Intermediate syndrome of platelet dysfunction. Blood 1978;52:103-13.202. Roderick PJ, Wilkes HC, Meade TW. The gastrointestinal toxicity of aspirin. An overview of randomizedcontrolledtrials. Br JClinPharmacol 1993;35:219-26.203. Steering Committee of the Physicians’ Health StudyResearch Group: Final report on the aspirincomponent of the ongoing Physician’ Health Study.N Engl J Med 1989;321:129.204. Ferraris VA, Ferraris S, Lough FC, Berry WR.Preoperative aspirin ingestion increases operativeblood loss after coronary artery bypass grafting. AnnThorac Surg 1988;45:71.205. Sethi GK, Copeland JG, Goldman S, et al. Implicationsof preoperative administration of aspirin in patientsundergoing coronary artery bypass grafting:Department of Veterans Affairs cooperative study ofantiplatelet therapy. J Am Coll Cardiol 1990;15:15.206. Amrein PC, Ellman L, Harris WH. Aspirin-inducedprolongation of bleeding time and perioperative bloodloss. JAMA 1981;245:1825-8.207. Kitchen L, Erichson RB, Sideropoulos H. Effect ofdrug-induced platelet dysfunction on surgicalbleeding. Am J Surg 1982;143:215-7.208. Mangano DT. Aspirin and mortality from coronarybypass surgery. N Engl J Med 2002;347:1309-17209. Mannucci PM. Desmopressin (DDAVP) in thetreatment of bleeding disorders: the first 20 years.Blood. 1997;90:2515-21.210. Sibai BM, Caritis SN, Thom E, et al. Low-doseaspirin in nulliparous women: Safety of continuousepidural block and correlation between bleeding timeand maternal-neonatal bleeding complications.National Institute of Child Health and HumanDevelopmental Maternal-Fetal Medicine Network. AmJ Obstet Gynecol 1995;172:1553-7.211. Horlocker TT, Wedel DJ, Schroeder DR, et al.วารสารโลหิตวิทยาและเวชศาสตรบริการโลหิต ปที่ 16 ฉบับที่ 2 เมษายน-มิถุนายน 2549